Impact of Pretransplant Infectious Diseases Wellness Visit on Vaccine Uptake in Solid Organ Transplant Candidates
Transplant Infectious Diseases, Henry Ford Hospital, Detroit, MI
Meeting: 2022 American Transplant Congress
Abstract number: 1189
Keywords: Infection, Screening, Vaccination
Topic: Clinical Science » Organ Inclusive » 70 - Non-Organ Specific: Disparities to Outcome and Access to Healthcare
Session Information
Session Name: Non-Organ Specific: Disparities to Outcome and Access to Healthcare
Session Type: Poster Abstract
Date: Sunday, June 5, 2022
Session Time: 7:00pm-8:00pm
Presentation Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
*Purpose: Vaccination rates in solid organ transplant candidates (SOTc) remains suboptimal. We report the effect of a dedicated Infectious Disease Pre-transplant (IDPT) clinic visit on vaccine uptake in SOTc.
*Methods: We evaluated all SOTc referred to the IDPT from January 2020 to February 2021 at Henry Ford Transplant Institute in Detroit, MI. Patients were followed up until October 2021. Sociodemographic data, comorbidities, vaccination status for influenza, pneumococcus, hepatitis B, Tdap, zoster and COVID-19 were determined from electronic medical records and the Michigan Care Improvement Registry that includes vaccination records. Vaccine uptake at baseline and 3 and 6 months after IDPT visit were evaluated.
*Results: A total of 183 SOTc were evaluated in IDPT. Median age was 57 years, mean Charlson Comorbidity Index was 4.1. Other characteristics are summarized (Table 1). Vaccine uptake improved post IDPT for all vaccines (Table 2), most notably for hepatitis B (53.4%), zoster (40.4%) and pneumococcal vaccine (33.4%). COVID vaccine uptake post visit was 80.3%.
*Conclusions: IDPT clinic visits steadily improved vaccine uptake in SOTc at our institution. Implementation of an Infectious Diseases visit as a requirement for all SOTc can provide opportunities to optimize vaccine completion before transplantation.
| Organ | N (%) |
| Heart | 46 (25.1) |
| Kidney | 67 (36.6) |
| Liver | 30 (16.4) |
| Lung | 33 (18) |
| Multivisceral | 6 (3.3) |
| Variable | Value |
| Age (year), median (IQR) | 57 (49-65) |
| Male sex (N, %) | 114 (62.3) |
| Race (N, %)-Black | 62 (33.9) |
| Insurance type (N, %)-Medicare | 94 (51.4) |
| Distance (miles) to center (mean, IQ) | 52.5 (13.5-62.2) |
| Charlson Comorbidity Index score (Mean, SD) | 4.1 (1.98) |
| IDPT clinic provider (N, %)-NP | 167 (91.3) |
| Vaccine | Eligible pre-transplant, N | Vaccination before IDPT visit, N (%) | Vaccination after IDPT visit at 3 months, N (%) | Vaccination after IDPT visit >6 months, N (%) | Vaccination uptake after IDPT visit, N (%) |
| Influenza | 183 | 98 (53.6) | 139 (76.0) | 147 (80.3) | 49 (26.8) |
| Pneumococcal | 183 | 77 (42.0) | 121 (66.1) | 138 (75.4) | 61 (33.3) |
| Hepatitis B | 103 (80/183 already HBV immune) | 31 (30.1) | 73 (70.9) | 86 (83.5) | 55 (53.4) |
| Tdap | 183 | 101 (55.2) | 130 (71.0) | 142 (77.5) | 41 (22.4) |
| Varicella (Shingrix) | 183 | 36 (19.7) | 101 (55.1) | 110 (60.1) | 74 (40.4) |
| COVID-19 | 183 | NA | 112 (61.2) | 147 (80.3) | – |
To cite this abstract in AMA style:
Jarrah J, Hanna Z, Williams J, McCorquodale J, Párraga T, Greenlee S, Lanfranco OAbreu, Ramesh M, Busto Rdel, Alangaden G. Impact of Pretransplant Infectious Diseases Wellness Visit on Vaccine Uptake in Solid Organ Transplant Candidates [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-pretransplant-infectious-diseases-wellness-visit-on-vaccine-uptake-in-solid-organ-transplant-candidates/. Accessed November 21, 2024.« Back to 2022 American Transplant Congress